Patents by Inventor Andrea A. Seymour

Andrea A. Seymour has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5225401
    Abstract: Congestive heart failure is treated by administration of a selective inhibitor of neutral endopeptidase and an angiotensin converting enzyme inhibitor. Captopril, fosinopril sodium, enalapril maleate and lisinopril are the preferred angiotensin converting enzyme inhibitors and the mercapto compounds of the formula ##STR1## are the preferred selective inhibitors of neutral endopeptidase.
    Type: Grant
    Filed: August 12, 1991
    Date of Patent: July 6, 1993
    Assignee: E. R. Squibb & Sons, Inc.
    Inventor: Andrea A. Seymour